Improved Structure and Function in Early-Detected Second-Eye Neovascular Age-Related Macular Degeneration: FASBAT/Early Detection of Neovascular Age-Related Macular Degeneration Report 1

Autor: Hopkins, Nicola, Downey, Louise, Menon, Geeta, Fletcher, Emily, Burton, Ben, Paget, James, Bindra, Mandeep, Pagliarini, Sergio, Ghanchi, Faruque, MacKenzie, Sarah, Stone, Amy, George, Sheena, Banerjee, Sanjiv, Vasileios, Konidaris, Dodds, Steven, Madhusudhan, Savita, Brand, Chris, Lotery, Andrew, Whistance-Smith, Diane, Empeslidis, Theo, Gale, Richard P., Airody, Archana, Sivaprasad, Sobha, Hanson, Rachel L.W., Allgar, Victoria, McKibbin, Martin, Morland, Antony B., Peto, Tunde, Porteous, Mia, Chakravarthy, Usha

Publikováno v: In Ophthalmology Retina June 2024 8(6):545-552

Improved Structure and Function in Early-Detected Second-Eye Neovascular Age-Related Macular Degeneration

Autor: Gale, Richard P., Airody, Archana, Sivaprasad, Sobha, Hanson, Rachel L.W., Allgar, Victoria, McKibbin, Martin, Morland, Antony B., Peto, Tunde, Porteous, Mia, Chakravarthy, Usha, Hopkins, Nicola, Downey, Louise, Menon, Geeta, Fletcher, Emily, Burton, Ben, Paget, James, Bindra, Mandeep, Pagliarini, Sergio, Ghanchi, Faruque, MacKenzie, Sarah, Stone, Amy, George, Sheena, Banerjee, Sanjiv, Vasileios, Konidaris, Dodds, Steven, Madhusudhan, Savita, Brand, Chris, Lotery, Andrew, Whistance-Smith, Diane, Empeslidis, Theo

Publikováno v: Ophthalmology Retina; June 2024, Vol. 8 Issue: 6 p545-552, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT Study.

Autor: Pagliarini, Sergio¹ sergio.pagliarini@gmail.com, Beatty, Stephen², Lipkova, Blandina³, Garcia, Eduardo Perez-Salvador⁴, Reynders, Stefaan⁵, Gekkieva, Margarita⁶, Bouazza, Abdelkader Si⁶, Pilz, Stefan⁶

Publikováno v: Journal of Ophthalmology. 2014, p1-9. 9p.

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

Autor: Lotery, Andrew, Sivaprasad, Sobha, O'Connell, Abby, Harris, Rosie A, Culliford, Lucy, Ellis, Lucy, Cree, Angela, Madhusudhan, Savita, Behar-Cohen, Francine, Chakravarthy, Usha, Peto, Tunde, Rogers, Chris A, Reeves, Barnaby C, Bellani, Samir, Griffiths, Helen, Thulasidharan, Suresh, Watkins, Catrin, Kaye, Rebecca, Menon, Deepthy, Neville, Qin, Denham, Rebecca, Gillvray, Karen, Abugreen, Salwa, Nixon, Natalie, Alarbi, Mohammed, Ghanchi, Faruque, Madanat, Zeid, Hawes, Nicola, Hughes, Edward, Keir, Campbell, Kisza, Krystian, Bailey, Clare, Hazlewood, Phillippa, Cloake, Julie, Menon, Geeta, Chandran, Manju, Raguro, Abigail, Mohamed, Moin, Lim, Wei Sing, Eleftheriadis, Haralabos, Efraimidis, Stefanos, McKibbin, Martin, Mukherjee, Raj, Wilson, Joanne, Lenfestey, Pauline, Harding, Simon, Haigh, Kelly, Chhabra, Ramandeep, Horani, Mania, Platt, Raisa-Marie, Talks, James, Bhatia, Devanga, Andrews, Violet, Downes, Susan, Samuel, Ivy, Buttress, Daniel, Pagliarini, Sergio, Randle, Linzi, Allison, Jeanette, Brand, Christopher, Edwards, Maria, Karia, Niral, Shipman, Maria, Thompson, Elridge, Kotagiri, Ajay, Steel, David, Dodds, Steven, Turner, Stephen, Osoba, Yinka, Criddle, Sharon, Yang, Yit, Narendran, Niro, Karpoor, Meena, Gale, Richard, Airody, Archana, Grice-Holt, Alison

Publikováno v: The Lancet; January 2020, Vol. 395 Issue: 10220 p294-303, 10p